About United BioSource Corporation
United BioSource Corporation is a company based in Blue Bell (United States) founded in 2003 was acquired by Avista Capital Partners in November 2017. United BioSource Corporation has raised $278 million across 3 funding rounds from investors including J P Morgan, PNC and Express Scripts. United BioSource Corporation has completed 5 acquisitions, including BioCor, Cognitive Drug Research and Examoto. United BioSource Corporation offers products and services including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions. United BioSource Corporation operates in a competitive market with competitors including Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others.
- Headquarter Blue Bell, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ubc Late Stage (Uk) Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$278 M (USD)
in 3 rounds
-
Latest Funding Round
$150 M (USD), Debt – Conventional
Jul 06, 2010
-
Investors
J P Morgan
& 9 more
-
Employee Count
Not available
-
Investments & Acquisitions
BioCor
& 4 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of United BioSource Corporation
United BioSource Corporation offers a comprehensive portfolio of products and services, including Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.
Solutions for generating real-world evidence and analytics.
Services to manage product safety and compliance.
Programs for improving therapy affordability and adherence.
Tools to accelerate innovation and data insights.
People of United BioSource Corporation
Unlock access to complete
Software Development Team
47 people
Leadership Team
30 people
Senior Team
28 people
Clinical Team
15 people
Safety Team
15 people
Data Analysis and Operations Team
15 people
Finance and Accounting
11 people
Sales and Marketing
9 people
Unlock access to complete
Funding Insights of United BioSource Corporation
United BioSource Corporation has successfully raised a total of $278M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $150 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in United BioSource Corporation
United BioSource Corporation has secured backing from 10 investors, including institutional and venture fund investors. Prominent investors backing the company include J P Morgan, PNC and Express Scripts.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward growth-stage companies.
|
Locked | Locked | Locked | |
|
Early-stage US tech startups are invested in by Grotech Ventures.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for United BioSource Corporation
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by United BioSource Corporation
United BioSource Corporation has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include BioCor, Cognitive Drug Research and Examoto.
Investment portfolio details for United BioSource Corporation
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
IT services are provided to the healthcare sector.
|
Locked | Locked | 2012 | Locked | |
|
Software solutions for pharmacovigilance reporting and analysis are provided.
|
Locked | Locked | 2000 | Locked | |
|
Pharmacy benefits are managed for healthcare clients by Pharmastar.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for United BioSource Corporation
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - United BioSource Corporation
Detailed financials for United BioSource Corporation
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
United Biosource Corporation Comparisons
Peer comparison for United BioSource Corporation
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of United BioSource Corporation
United BioSource Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Launch Therapeutics, Xgene Pharmaceutical, Hikinger Pharmaceutical Technology, Ipsum and Concentrics Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Late-stage clinical development services are provided for biopharma companies.
|
|
| Locked | Locked | Locked |
Developer of pharmaceutical products for treating neurological diseases and chronic pain
|
|
| Locked | Locked | Locked |
Phase I-IV drug research and development services are provided.
|
|
| Locked | Locked | Locked |
Full-service CRO support for Phase II-IV clinical trials is provided.
|
|
| Locked | Locked | Locked |
Late-stage (Phase II-IV trials) CRO
|
Detailed competitors of United BioSource Corporation
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on United Biosource Corporation
Complete news archive for United BioSource Corporation
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about United BioSource Corporation
United BioSource Corporation was founded in 2003.
United BioSource Corporation is headquartered in Blue Bell, United States. It is registered at Blue Bell, Pennsylvania, United States.
United BioSource Corporation is a funded company, having raised a total of $278M across 3 funding rounds to date.
United BioSource Corporation provides pharmaceutical support services. Services include clinical development and late stage clinical research, trial management, risk monitoring, risk evaluation and mitigation strategies, risk management plans, reimbursement patient assistance, along with support programs designed to enhance patients adherence. It also offers CLÆRITY and SÆfetyworks web based analytical softwares and has partnered with Accredo Specialty Pharmacy and CuraScript Specialty Distribution to help pharmaceutical and biotech manufacturers maximize product access and commercialization.
United BioSource Corporation's top competitors include Xgene Pharmaceutical, Concentrics Research and Hikinger Pharmaceutical Technology.
United BioSource Corporation offers Evidence Development, Safety and Risk Management, Patient Access, and Technology Solutions.
United BioSource Corporation has made 5 acquisitions, including BioCor, Cognitive Drug Research, and Examoto.
United BioSource Corporation has 10 investors. Key investors include J P Morgan, PNC, Express Scripts, Wells Fargo, and Berkshire Partners.